1. Home
  2. BCBP vs FATE Comparison

BCBP vs FATE Comparison

Compare BCBP & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$10.25

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.40

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
FATE
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
125.6M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
BCBP
FATE
Price
$10.25
$2.40
Analyst Decision
Hold
Buy
Analyst Count
2
6
Target Price
$10.00
$4.10
AVG Volume (30 Days)
164.8K
4.1M
Earning Date
04-21-2026
05-14-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
29.88
EPS
0.26
N/A
Revenue
N/A
$6,646,000.00
Revenue This Year
$85.26
N/A
Revenue Next Year
$6.14
N/A
P/E Ratio
$38.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.31
$0.91
52 Week High
$11.71
$3.23

Technical Indicators

Market Signals
Indicator
BCBP
FATE
Relative Strength Index (RSI) 46.51 43.14
Support Level $9.67 $1.01
Resistance Level $10.60 $3.22
Average True Range (ATR) 0.28 0.22
MACD -0.01 -0.08
Stochastic Oscillator 51.55 1.19

Price Performance

Historical Comparison
BCBP
FATE

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: